JenaValve Technology Overview
- Year Founded
-
2006

- Status
-
Private
- Employees
-
148

- Latest Deal Type
-
M&A
- (Announced)
- Financing Rounds
-
14
JenaValve Technology General Information
Description
Developer and manufacturer of transcatheter aortic valve replacement (TAVR) systems intended for patients suffering from structural heart conditions. The company offers porcine pericardial tissue and a self-expanding nitinol frame with a transfemoral delivery system, anatomically-based locator fixation and dual-sealing valve design, thereby providing awareness and transforming the treatment of severe aortic regurgitation.
Contact Information
Website
www.jenavalve.comCorporate Office
- 4 Cromwell
- Irvine, CA 92618
- United States
Corporate Office
- 4 Cromwell
- Irvine, CA 92618
- United States
JenaValve Technology Timeline
JenaValve Technology Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
JenaValve Technology Comparisons
Industry
Financing
Details
JenaValve Technology Competitors (13)
One of JenaValve Technology’s 13 competitors is Coramaze Technologies, a Venture Capital-Backed company based in Tel Aviv, Israel.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Coramaze Technologies | Venture Capital-Backed | Tel Aviv, Israel | ||||
Micro Interventional Devices | Venture Capital-Backed | Newtown, PA | ||||
Foldax | Venture Capital-Backed | Salt Lake City, UT | ||||
Xeltis | Venture Capital-Backed | Eindhoven, Netherlands | ||||
Spine Wave | Venture Capital-Backed | Shelton, CT |
JenaValve Technology Patents
JenaValve Technology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240164903-A1 | Catheter system for sequential deployment of an expandable implant | Pending | 23-Nov-2022 | ||
US-20240164902-A1 | Catheter system for sequential deployment of an expandable implant | Pending | 23-Nov-2022 | ||
US-20240164899-A1 | Catheter system for sequential deployment of an expandable implant | Pending | 23-Nov-2022 | ||
US-20240148503-A1 | Catheter system for sequential deployment of an expandable implant | Active | 09-Nov-2022 | ||
US-12171658-B2 | Catheter system for sequential deployment of an expandable implant | Active | 09-Nov-2022 | A61F2/2436 |
JenaValve Technology Signals
JenaValve Technology Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
JenaValve Technology FAQs
-
When was JenaValve Technology founded?
JenaValve Technology was founded in 2006.
-
Where is JenaValve Technology headquartered?
JenaValve Technology is headquartered in Irvine, CA.
-
What is the size of JenaValve Technology?
JenaValve Technology has 148 total employees.
-
What industry is JenaValve Technology in?
JenaValve Technology’s primary industry is Therapeutic Devices.
-
Is JenaValve Technology a private or public company?
JenaValve Technology is a Private company.
-
What is the current valuation of JenaValve Technology?
The current valuation of JenaValve Technology is
. -
What is JenaValve Technology’s current revenue?
The current revenue for JenaValve Technology is
. -
How much funding has JenaValve Technology raised over time?
JenaValve Technology has raised $502M.
-
Who are JenaValve Technology’s investors?
Rosetta Capital (UK), Cormorant Asset Management, Innovatus Capital Partners, Peijia Medical, and Pictet are 5 of 16 investors who have invested in JenaValve Technology.
-
Who are JenaValve Technology’s competitors?
Coramaze Technologies, Micro Interventional Devices, Foldax, Xeltis, and Spine Wave are some of the 13 competitors of JenaValve Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »